Hollywood Mark — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Hollywood Mark has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $139K.

Profile

Hollywood Mark

Mark Hollywood is listed in SEC filing CIK 0002104446 as EVP and Chief Operating Officer of Zymeworks Inc., a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics including zanidatamab. The filing dated 2026-01-13 reports no insider purchases or sales by Hollywood and identifies him in Zymeworks' executive leadership.

RoleEVP & Chief Operating Officer
Notability40/100

Board memberships

Awards & honors

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-07-06ZYMEZymeworks Inc.A — Grant or award939$22.22$21K
2026-01-13ZYMEZymeworks Inc.S — Open-market sale6.1K$22.67$139K
2026-01-13ZYMEZymeworks Inc.M — Option exercise17.7K$0.00

Companies — Last 90 Days

Frequently Asked Questions

Who is Hollywood Mark?

Mark Hollywood is listed in SEC filing CIK 0002104446 as EVP and Chief Operating Officer of Zymeworks Inc., a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics including zanidatamab. The filing dated 2026-01-13 reports no insider purchases or sales by Hollywood and identifies him in Zymeworks' executive leadership.…

How many SEC Form 4 filings has Hollywood Mark submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Has Hollywood Mark been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 1 open-market sales ($139K) across all tracked filings.

Where can I see all of Hollywood Mark's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live Hollywood Mark profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.